文献速递生殖医学

第3天仅有1-3枚胚胎的患者是否应进行囊胚移植?

Should blastocyst transfer be performed in patients with 1-3 embryos available on day 3?
PubMed 文献 · Reprod Biomed Online · 2022-08-13

该回顾性观察研究纳入2019年1月1日至2020年12月31日在昆明医科大学第二附属医院生殖与生育中心进行的423个IVF周期,比较卵裂期移植267个周期与囊胚移植156个周期的结局。两组持续妊娠率(25.84% vs 26.92%;OR 0.95;95%CI 0.61-1.50;P=0.82)和胚胎停止发育率(83.48% vs 85.75%;OR 1.19;95%CI 0.82-1.75;P=0.40)无差异,logistic回归显示移植阶段与持续妊娠率无关联(OR 1.06;95%CI 0.64-1.73)。结论认为囊胚移植不降低临床妊娠机会,支持在第3天仅有1-3枚胚胎的患者中进行囊胚移植。

要点

  • 第3天有1-3枚胚胎时,囊胚移植与卵裂期移植的持续妊娠率无显著差异。
  • 两组胚胎停止发育率无显著差异。
  • 多因素分析未显示移植阶段与持续妊娠率存在关联。

核心结论

  • 囊胚移植不降低临床妊娠机会,结果支持在第3天有1-3枚胚胎的患者中提出囊胚移植。

研究设计与样本

  • 回顾性观察研究,纳入2019年1月1日至2020年12月31日在昆明医科大学第二附属医院生殖与生育中心进行的423个IVF周期。
  • 卵裂期移植267个周期,囊胚移植156个周期。
  • 主要结局为持续妊娠率,次要结局为临床妊娠率和胚胎停止发育率。
  • 采用单因素分析比较结局,并采用logistic回归分析探讨移植阶段与持续妊娠率的关联。

主要发现

  • 持续妊娠率卵裂期移植组25.84% vs 囊胚移植组26.92%(OR 0.95;95%CI 0.61-1.50;P=0.82),两组无差异。
  • 胚胎停止发育率卵裂期移植组83.48% vs 囊胚移植组85.75%(OR 1.19;95%CI 0.82-1.75;P=0.40),两组无差异。
  • logistic回归分析显示移植阶段与持续妊娠率无关联(OR 1.06;95%CI 0.64-1.73)。

临床怎么用

  • 作者结论认为囊胚移植不降低临床妊娠机会,结果支持在第3天有1-3枚胚胎的患者中提出囊胚移植。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: In patients with 1-3 embryos available on day 3, does blastocyst transfer reduce the chances of a clinical pregnancy by cancelling transfer cycles compared with cleavage transfer? DESIGN: This retrospective observational study included 423 IVF cycles performed from 1 January 2019 to 31 December 2020 at the Center for Reproduction and Fertility of the Second Affiliated Hospital of Kunming Medical University. Cleavage transfer was performed in 267 cycles and blastocyst transfer was performed in 156 cycles. The primary outcome was the ongoing pregnancy rate, and the secondary outcomes were clinical pregnancy rate and embryo cessation rate. Univariate analysis was performed to compare outcomes. A logistic regression analysis was performed to explore the association between transfer stage and ongoing pregnancy rate. RESULTS: No differences were observed in the ongoing pregnancy rate (25.84% versus 26.92%; odds ratio [OR] 0.95; 95% confidence interval [CI] 0.61-1.50; P = 0.82) and embryo cessation rate (83.48% versus 85.75%; OR 1.19; 95% CI 0.82-1.75; P = 0.40) between the two groups. Logistic regression analysis showed no association between transfer stage and ongoing pregnancy rate (OR 1.06; 95% CI 0.64-1.73). CONCLUSIONS: Blastocyst transfer does not reduce the chances of a clinical pregnancy. These results support the proposal of blastocyst transfer in patients with 1-3 embryos available on day 3.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Yang J, Li D, Zha H, et al. Should blastocyst transfer be performed in patients with 1-3 embryos available on day 3? Reprod Biomed Online. 2022. PMID: 36151011. doi:10.1016/j.rbmo.2022.08.100

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。